PL374537A1 - Sposób zwiększania ekspresji antygenu nowotworowego z użyciem tymalfazyny - Google Patents

Sposób zwiększania ekspresji antygenu nowotworowego z użyciem tymalfazyny

Info

Publication number
PL374537A1
PL374537A1 PL03374537A PL37453703A PL374537A1 PL 374537 A1 PL374537 A1 PL 374537A1 PL 03374537 A PL03374537 A PL 03374537A PL 37453703 A PL37453703 A PL 37453703A PL 374537 A1 PL374537 A1 PL 374537A1
Authority
PL
Poland
Prior art keywords
thymalfasin
tumor antigen
antigen expression
regulating tumor
regulating
Prior art date
Application number
PL03374537A
Other languages
English (en)
Inventor
Guido Rasi
Enrico Garaci
Paola Sinibaldi-Vallebona
Original Assignee
Sciclone Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals, Inc. filed Critical Sciclone Pharmaceuticals, Inc.
Publication of PL374537A1 publication Critical patent/PL374537A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL03374537A 2002-06-28 2003-06-30 Sposób zwiększania ekspresji antygenu nowotworowego z użyciem tymalfazyny PL374537A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39196902P 2002-06-28 2002-06-28

Publications (1)

Publication Number Publication Date
PL374537A1 true PL374537A1 (pl) 2005-10-31

Family

ID=30000788

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374537A PL374537A1 (pl) 2002-06-28 2003-06-30 Sposób zwiększania ekspresji antygenu nowotworowego z użyciem tymalfazyny

Country Status (14)

Country Link
US (1) US20060052297A1 (pl)
EP (1) EP1539211A4 (pl)
JP (1) JP2005537246A (pl)
CN (1) CN1665522A (pl)
AU (1) AU2003248792B2 (pl)
BR (1) BR0312270A (pl)
CA (1) CA2490868A1 (pl)
EA (1) EA006599B1 (pl)
IL (1) IL166004A0 (pl)
MX (1) MXPA05000078A (pl)
NO (1) NO20050320L (pl)
NZ (1) NZ537867A (pl)
PL (1) PL374537A1 (pl)
WO (1) WO2004003174A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101072582B (zh) 2004-12-06 2012-06-27 赛生制药有限公司 作为癌症疫苗佐剂的α胸腺肽

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100974A1 (de) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
US4517119A (en) * 1983-04-04 1985-05-14 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers

Also Published As

Publication number Publication date
MXPA05000078A (es) 2005-04-11
EA200500071A1 (ru) 2005-08-25
EP1539211A4 (en) 2007-05-23
JP2005537246A (ja) 2005-12-08
BR0312270A (pt) 2005-04-26
NZ537867A (en) 2007-04-27
EA006599B1 (ru) 2006-02-24
CA2490868A1 (en) 2004-01-08
IL166004A0 (en) 2006-01-15
AU2003248792C1 (en) 2004-01-19
WO2004003174A2 (en) 2004-01-08
WO2004003174A3 (en) 2004-05-06
CN1665522A (zh) 2005-09-07
US20060052297A1 (en) 2006-03-09
AU2003248792B2 (en) 2007-06-21
EP1539211A2 (en) 2005-06-15
AU2003248792A1 (en) 2004-01-19
NO20050320L (no) 2005-01-20

Similar Documents

Publication Publication Date Title
IL175935A0 (en) Solid forms of anti-egfr antibodies
GB0308731D0 (en) Method of radiotherapy
EP1572131A4 (en) ANTIBODY THERAPY
AU2003226301A8 (en) Method of treating cancer
AU2003293333A8 (en) Method of treating cancers
AU2003256847A8 (en) Method of treating cancer
SI1587542T1 (sl) Uporaba anti-cd100 protiteles
EP1577280A4 (en) DEUTERATION PROCESS
AU2003213718A8 (en) Method of producing antigens
GB0216780D0 (en) Methods of particle formation
EP1549343A4 (en) PROCESS FOR TREATING NEPHRITIS WITH ANTI-PDGF-DD ANTIBODIES
GB0201504D0 (en) Method of payment
AU2003302822A8 (en) Antibodies to treat cancer
EP1488046A4 (en) CONSTRUCTION METHODS
GB0210741D0 (en) Methods of therapy
EP1553965A4 (en) TUMOR TREATMENT METHOD
IL166004A0 (en) Method of up-regulating tumor antigen expression using thymalfasin
GB0217493D0 (en) Novel methods of treatment
GB0208897D0 (en) New method of treatment
GB0221712D0 (en) Methods of treatment
PL381165A1 (pl) Sposób transportowania energii
AU2003290625A1 (en) Method of screening tumor antigen
GB0222736D0 (en) Method of authentication
AU2003293581A8 (en) Method of identifying therapeutic agents
AU2003245691A1 (en) Method of radio-labelling biomolecules

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)